{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:59:55Z","timestamp":1764842395095,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010133","name":"Aarne Koskelon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paavo Ilmari Ahvenaisen S\u00e4\u00e4tio"},{"name":"Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>There is limited information on the longer-term outcome after transcatheter aortic valve replacement (TAVR) with new-generation prostheses compared to surgical aortic valve replacement (SAVR). The aim of this study was to compare the mid-term outcomes after TAVR with Sapien 3 and SAVR with Perimount Magna Ease bioprostheses for severe aortic stenosis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In a retrospective study, we included patients who underwent transfemoral TAVR with Sapien 3 or SAVR with Perimount Magna Ease bioprosthesis between January 2008 and October 2017 from the nationwide FinnValve registry. Propensity score matching was performed to adjust for differences in the baseline characteristics. The Kaplan-Meir method was used to estimate late mortality.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 2000 patients were included (689 in the TAVR cohort and 1311 in the SAVR cohort). Propensity score matching resulted in 308 pairs (STS score, TAVR 3.5\u2009\u00b1\u20092.2% vs. SAVR 3.5\u2009\u00b1\u20092.8%, <jats:italic>p<\/jats:italic>\u2009=\u20090.918). In-hospital mortality was 3.6% after SAVR and 1.3% after TAVR (<jats:italic>p<\/jats:italic>\u2009=\u20090.092). Stroke, acute kidney injury, bleeding and atrial fibrillation were significantly more frequent after SAVR, but higher rate of vascular complications was observed after TAVR. The cumulative incidence of permanent pacemaker implantation at 4\u2009years was 13.9% in the TAVR group and 6.9% in the SAVR group (<jats:italic>p<\/jats:italic>\u2009=\u20090.0004). At 4-years, all-cause mortality was 20.6% for SAVR and 25.9% for TAVR (<jats:italic>p<\/jats:italic>\u2009=\u20090.910). Four-year rates of coronary revascularization, prosthetic valve endocarditis and repeat aortic valve intervention were similar between matched cohorts.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The Sapien 3 bioprosthesis achieves comparable midterm outcomes to a surgical bioprosthesis with proven durability such as the Perimount Magna Ease. However, the Sapien 3 bioprosthesis was associated with better early outcome.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03385915\">NCT03385915<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13019-020-01203-1","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T16:04:37Z","timestamp":1593446677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-0772","authenticated-orcid":false,"given":"Marko P. O.","family":"Virtanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Eskola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Savontaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatu","family":"Juvonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annastiina","family":"Husso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maina P.","family":"Jalava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomas","family":"Tauriainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomas","family":"Ahvenvaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasi","family":"Maaranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eeva-Maija","family":"Kinnunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dahlbacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Laine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"M\u00e4kikallio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Valtola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Raivio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"D\u2019Errigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Vento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Biancari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"1203_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","volume":"385","author":"MJ Mack","year":"2015","unstructured":"Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477\u201384.","journal-title":"Lancet."},{"key":"1203_CR2","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609\u201320.","journal-title":"N Engl J Med"},{"key":"1203_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695\u2013705.","journal-title":"N Engl J Med"},{"key":"1203_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","volume":"376","author":"MJ Reardon","year":"2017","unstructured":"Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, S\u00f8ndergaard L, Mumtaz M, et al. Surgical or Transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321\u201331.","journal-title":"N Engl J Med"},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O\u2019Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706\u201315.","journal-title":"N Engl J Med"},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","volume":"72","author":"TG Gleason","year":"2018","unstructured":"Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, et al. 5-year outcomes of self-expanding Transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018;72:2687\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"1203_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacc.2018.10.083","volume":"73","author":"L S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard L, Ihlemann N, Capodanno D, J\u00f8rgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of Transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73:546\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"1203_CR8","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","volume":"40","author":"GCM Siontis","year":"2019","unstructured":"Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019;40:3143\u201353.","journal-title":"Eur Heart J"},{"key":"1203_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jtcvs.2018.02.092","volume":"156","author":"X Armoiry","year":"2018","unstructured":"Armoiry X, Obadia JF, Pascal L, Polazzi S, Duclos A. Comparison of transcatheter versus surgical aortic valve implantation in high-risk patients: A nationwide study in France. J Thorac Cardiovasc Surg. 2018;156:1017\u20131025.e4.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1203_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/ejcts\/ezz245","volume":"56","author":"A Schaefer","year":"2019","unstructured":"Schaefer A, Schofer N, Go\u00dfling A, Seiffert M, Schirmer J, Deuschl F, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis. Eur J Cardio-Thoracic Surg. 2019;56:1131\u20139.","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"1203_CR11","doi-asserted-by":"publisher","first-page":"e007825","DOI":"10.1161\/CIRCINTERVENTIONS.119.007825","volume":"12","author":"M Barbanti","year":"2019","unstructured":"Barbanti M, Tamburino C, D\u2019Errigo P, Biancari F, Ranucci M, Rosato S, et al. Five-year outcomes of Transfemoral Transcatheter aortic valve replacement or surgical aortic valve replacement in a real world population. Circ Cardiovasc Interv. 2019;12:e007825.","journal-title":"Circ Cardiovasc Interv"},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"e195742","DOI":"10.1001\/jamanetworkopen.2019.5742","volume":"2","author":"MPO Virtanen","year":"2019","unstructured":"Virtanen MPO, Eskola M, Jalava MP, Husso A, Laakso T, Niemel\u00e4 M, et al. Comparison of outcomes after Transcatheter aortic valve replacement vs surgical aortic valve replacement among patients with aortic stenosis at low operative risk. JAMA Netw Open. 2019;2:e195742.","journal-title":"JAMA Netw Open"},{"key":"1203_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamacardio.2017.3306","volume":"2","author":"PS Douglas","year":"2017","unstructured":"Douglas PS, Leon MB, Mack MJ, Svensson LG, Webb JG, Hahn RT, et al. Longitudinal hemodynamics of transcatheter and surgical aortic valves in the PARTNER trial. JAMA Cardiol. 2017;2:1197\u2013206.","journal-title":"JAMA Cardiol"},{"key":"1203_CR14","unstructured":"Pibarot P, Hahn R. Incidence, predictors and outcome of structural valve deterioration in transcatheter vs. SAVR: five year follow-up from the PARTNER II trials in intermediate-risk patients. Data presented in PCR London Valves 18th November ; London; United Kingdom. https:\/\/www.pcronline.com\/Cases-resources-images\/Resources\/Course-videos-slides\/2019\/Late-Breaking-Trials-at-PCR-London-Valves-2019-Session-2?auth=true. Accessed 17 Mar 2020."},{"key":"1203_CR15","doi-asserted-by":"publisher","unstructured":"Schymik G, Wendler O, Hengstenberg C, et al. Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations. Catheter Cardiovasc Interv. 2019:1\u201310. https:\/\/doi.org\/10.1002\/ccd.28621.","DOI":"10.1002\/ccd.28621"},{"key":"1203_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.119.043785","volume":"141","author":"E Van Belle","year":"2020","unstructured":"Van Belle E, Vincent F, Labreuche J, Auffret V, Debry N, Lef\u00e8vre T, et al. Balloon-expandable versus self-expanding Transcatheter aortic valve replacement. Circulation. 2020;141:243\u201359.","journal-title":"Circulation."},{"key":"1203_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.athoracsur.2013.03.032","volume":"96","author":"J Forcillo","year":"2013","unstructured":"Forcillo J, Pellerin M, Perrault LP, Cartier R, Bouchard D, Demers P, et al. Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. Ann Thorac Surg. 2013;96:486\u201393.","journal-title":"Ann Thorac Surg"},{"key":"1203_CR18","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/ejcts\/ezv432","volume":"49","author":"PH Nielsen","year":"2016","unstructured":"Nielsen PH, Hjortdal V, Modrau IS, Jensen H, Kimose H-H, Terp K, et al. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-Centre experience in 2393 patients. Eur J Cardio-Thoracic Surg. 2016;49:1705\u201310.","journal-title":"Eur J Cardio-Thoracic Surg."},{"key":"1203_CR19","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.","journal-title":"PLoS Med"},{"key":"1203_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"SAM Nashef","year":"2012","unstructured":"Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardio-Thoracic Surg. 2012;41:734\u201345.","journal-title":"Eur J Cardio-Thoracic Surg."},{"key":"1203_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(98)04402-X","volume":"353","author":"K Rockwood","year":"1999","unstructured":"Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205\u20136.","journal-title":"Lancet."},{"key":"1203_CR22","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","volume":"33","author":"AP Kappetein","year":"2012","unstructured":"Kappetein AP, Head SJ, G\u00e9n\u00e9reux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research Consortium-2 consensus document\u2020. Eur Heart J. 2012;33:2403\u201318.","journal-title":"Eur Heart J"},{"key":"1203_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13019-015-0292-z","volume":"10","author":"F Biancari","year":"2015","unstructured":"Biancari F, Ruggieri VG, Perrotti A, Svenarud P, Dal\u00e9n M, Onorati F, et al. European multicenter study on coronary artery bypass grafting (E-CABG registry): study protocol for a prospective clinical registry and proposal of classification of postoperative complications. J Cardiothorac Surg. 2015;10:90.","journal-title":"J Cardiothorac Surg"},{"key":"1203_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2011.32","volume":"2","author":"Acute Kidney Injury Work Group","year":"2012","unstructured":"Acute Kidney Injury Work Group. Section 2: AKI definition. Kidney Int Suppl. 2012;2:19\u201336.","journal-title":"Kidney Int Suppl"},{"key":"1203_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/jamacardio.2017.3425","volume":"2","author":"P Pibarot","year":"2017","unstructured":"Pibarot P, Hahn RT, Weissman NJ, Arsenault M, Beaudoin J, Bernier M, et al. Association of paravalvular regurgitation with 1-year outcomes after transcatheter aortic valve replacement with the SAPIEN 3 valve. JAMA Cardiol. 2017;2:1208\u201316.","journal-title":"JAMA Cardiol"},{"key":"1203_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamacardio.2018.4045","volume":"4","author":"B Fatima","year":"2019","unstructured":"Fatima B, Mohananey D, Khan FW, Jobanputra Y, Tummala R, Banerjee K, et al. Durability data for bioprosthetic surgical aortic valve. JAMA Cardiol. 2019;4:71\u201380.","journal-title":"JAMA Cardiol"},{"key":"1203_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4244\/EIJ-D-18-01060","volume":"15","author":"G Costa","year":"2019","unstructured":"Costa G, Zappulla P, Barbanti M, Cirasa A, Todaro D, Rapisarda G, et al. Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes. EuroIntervention. 2019;15:875\u201383.","journal-title":"EuroIntervention."},{"key":"1203_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcin.2015.09.036","volume":"9","author":"O Husser","year":"2016","unstructured":"Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable Transcatheter heart valve. JACC Cardiovasc Interv. 2016;9:244\u201354.","journal-title":"JACC Cardiovasc Interv"},{"key":"1203_CR29","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.jcin.2016.08.034","volume":"9","author":"V Mauri","year":"2016","unstructured":"Mauri V, Reimann A, Stern D, Scherner M, Kuhn E, Rudolph V, et al. Predictors of permanent pacemaker implantation after Transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv. 2016;9:2200\u20139.","journal-title":"JACC Cardiovasc Interv."},{"key":"1203_CR30","first-page":"e521","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA\/ACC guideline for the Management of Patients with Valvular Heart Disease. Circulation. 2014;129:e521\u2013643.","journal-title":"Circulation."},{"key":"1203_CR31","doi-asserted-by":"publisher","first-page":"e1169","DOI":"10.4244\/EIJ-D-18-00098","volume":"14","author":"F D\u2019Ascenzo","year":"2018","unstructured":"D\u2019Ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018;14:e1169\u201377.","journal-title":"EuroIntervention."}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-020-01203-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:20:32Z","timestamp":1624926032000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-01203-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-01203-1","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the local Institutional Review Boards in each participating centre.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MS is a proctor for Medtronic; ML is a proctor for Boston Scientific All the other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}